Current Affairs - Business - Discussion

Sun Pharma has announced a major international acquisition plan to purchase Organon & Co. for $11.75 billion in an all-cash deal. This move represents one of the largest overseas acquisitions by an Indian company and highlights its strategy to expand globally. The acquisition will significantly strengthen its footprint across multiple countries and enhance its presence in high-growth segments like women’s health and biosimilars. With Organon’s extensive product portfolio and global reach, Sun Pharma aims to become a leading global pharmaceutical player while reducing dependence on traditional generics.